Last updated on February 2018

DNS-3379 vs. Placebo in Stroke Rehabilitation

Brief description of study

This is a randomized, double-blind, placebo-controlled parallel group outpatient 42-day treatment study that will utilize standard stroke rehabilitation outcome measures to evaluate the effect of DNS-3379 on upper extremity motor recovery in subjects following ischemic stroke.

Clinical Study Identifier: NCT03254160

Contact Investigators or Research Sites near you

Start Over

Dart Neuroscience. LLC

Repatriation General Hospital
Daw Park, Australia
  Connect »

Dart Neuroscience. LLC

Royal Adelaide Hospital
Adelaide, Australia
  Connect »